US EditionPublished • loading... • Updated
ACTG Presents SLIM LIVER Findings at AASLD Liver Meeting Demonstrating Improvements in Biomarkers of Cardiovascular Risk among People Living with HIV and MASLD Who Receive Semaglutide
Summary by Globe Newswire
10 Articles
10 Articles
Globe Newswire+9 Reposted by 9 other sources
ACTG Presents SLIM LIVER Findings at AASLD Liver Meeting Demonstrating Improvements in Biomarkers of Cardiovascular Risk among People Living with HIV and MASLD Who Receive Semaglutide
Treating people living with HIV and metabolic dysfunction-associated MASLD with semaglutide significantly improved biomarkers of cardiovascular risk....
Coverage Details
Total News Sources10
Leaning Left8Leaning Right1Center1Last UpdatedBias Distribution80% Left
Bias Distribution
- 80% of the sources lean Left
80% Left
L 80%
Factuality
To view factuality data please Upgrade to Premium
